We've found
					184,457 				
					clinical trials				
				
			
		
							
  	
	Chronic Idiopathic Constipation Clinical Trial
	A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 4/25/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Idiopathic Constipation Clinical Trial
	A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Chronic Idiopathic Constipation Clinical Trial
	A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 4/25/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Idiopathic Constipation Clinical Trial
	A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Chronic Idiopathic Constipation Clinical Trial
	A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 4/25/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Healthy Clinical Trial
	Study of the Physical Activity in Anesthesiologists
		Status: Enrolling
  
							
  	
	Healthy Clinical Trial
	Study of the Physical Activity in Anesthesiologists
		Status: Enrolling	
	
	
			Updated: 2/19/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Nicotine Dependence Clinical Trial
	Very Low-Nicotine Cigarettes in Smokers With SUD
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Nicotine Dependence Clinical Trial
	Very Low-Nicotine Cigarettes in Smokers With SUD
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 2/16/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Oncology Clinical Trial
	Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Oncology Clinical Trial
	Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Oncology Clinical Trial
	Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Metastatic Breast Cancer Clinical Trial
	Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Metastatic Breast Cancer Clinical Trial
	Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 3/6/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Metastatic Breast Cancer Clinical Trial
	Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Metastatic Breast Cancer Clinical Trial
	Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 3/6/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Metastatic Breast Cancer Clinical Trial
	Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Metastatic Breast Cancer Clinical Trial
	Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 3/6/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Metastatic Breast Cancer Clinical Trial
	Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Metastatic Breast Cancer Clinical Trial
	Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 3/6/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Study of Use of CTC in NSCLC
		Status: Enrolling
  
							
  	
	Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Study of Use of CTC in NSCLC
		Status: Enrolling	
	
	
			Updated: 11/15/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Rhinitis  Sinusitis Pediatric Chronic Rhinosinusitis Clinical Trial
	Study for the Management of Pediatric Chronic Rhinosinusitis With or Without Balloon Sinuplasty
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Rhinitis  Sinusitis Pediatric Chronic Rhinosinusitis Clinical Trial
	Study for the Management of Pediatric Chronic Rhinosinusitis With or Without Balloon Sinuplasty
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/11/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Influenza Clinical Trial
	Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Influenza Clinical Trial
	Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 1/13/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)
		Status: Enrolling,
							Phase
  
							
  	
	Breast Cancer Clinical Trial
	Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Abdominal Aortic Aneurysm (AAA) Clinical Trial
	Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
		Status: Enrolling
  
							
  	
	Abdominal Aortic Aneurysm (AAA) Clinical Trial
	Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
		Status: Enrolling	
	
	
			Updated: 8/1/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Abdominal Aortic Aneurysm (AAA) Clinical Trial
	Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
		Status: Enrolling
  
							
  	
	Abdominal Aortic Aneurysm (AAA) Clinical Trial
	Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
		Status: Enrolling	
	
	
			Updated: 8/1/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Abdominal Aortic Aneurysm (AAA) Clinical Trial
	Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
		Status: Enrolling
  
							
  	
	Abdominal Aortic Aneurysm (AAA) Clinical Trial
	Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
		Status: Enrolling	
	
	
			Updated: 8/1/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/12/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/12/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/12/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/12/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/12/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/12/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/12/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/12/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/12/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/12/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling
  
							
  	
	Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	
	
			Updated: 10/7/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling
  
							
  	
	Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	
	
			Updated: 10/7/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling
  
							
  	
	Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	
	
			Updated: 10/7/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling
  
							
  	
	Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	
	
			Updated: 10/7/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling
  
							
  	
	Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	
	
			Updated: 10/7/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling
  
							
  	
	Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	
	
			Updated: 10/7/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling
  
							
  	
	Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	
	
			Updated: 10/7/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling
  
							
  	
	Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	
	
			Updated: 10/7/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling
  
							
  	
	Genetics of Drug Metabolism Clinical Trial
	Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	
	
			Updated: 10/7/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Cryoablation of Small Breast Tumors in Early Stage Breast Cancer
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Breast Cancer Clinical Trial
	Cryoablation of Small Breast Tumors in Early Stage Breast Cancer
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/19/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Cryoablation of Small Breast Tumors in Early Stage Breast Cancer
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Breast Cancer Clinical Trial
	Cryoablation of Small Breast Tumors in Early Stage Breast Cancer
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/19/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Multiple Sclerosis Clinical Trial
	Body Weight Supported Treadmill Training in Persons With Multiple Sclerosis
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Multiple Sclerosis Clinical Trial
	Body Weight Supported Treadmill Training in Persons With Multiple Sclerosis
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 9/3/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Reproductive Clinical Trial
	MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
		Status: Enrolling
  
							
  	
	Oncology, Reproductive Clinical Trial
	MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Reproductive Clinical Trial
	MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
		Status: Enrolling
  
							
  	
	Oncology, Reproductive Clinical Trial
	MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology Clinical Trial
	Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Urinary Tract Infections Clinical Trial
	Seven vs. 14 Days Treatment for Male Urinary Tract Infection
		Status: Enrolling
  
							
  	
	Urinary Tract Infections Clinical Trial
	Seven vs. 14 Days Treatment for Male Urinary Tract Infection
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Hematology, Oncology Clinical Trial
	Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Hematology, Oncology Clinical Trial
	Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Lymphoma Clinical Trial
	Lenalidomide and GA101 in Relapsed Indolent Non-Hodgkin's Lymphoma
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Lymphoma Clinical Trial
	Lenalidomide and GA101 in Relapsed Indolent Non-Hodgkin's Lymphoma
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Acromegaly Clinical Trial
	An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Stages I Through III Clinical Trial
	The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients
		Status: Enrolling
  
							
  	
	Breast Cancer Stages I Through III Clinical Trial
	The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients
		Status: Enrolling	
	
	
			Updated: 7/26/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cerebral Vasospasm Clinical Trial
	The Intra-arterial Vasospasm Trial
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cerebral Vasospasm Clinical Trial
	The Intra-arterial Vasospasm Trial
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cerebral Vasospasm Clinical Trial
	The Intra-arterial Vasospasm Trial
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cerebral Vasospasm Clinical Trial
	The Intra-arterial Vasospasm Trial
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Paroxysmal Atrial Fibrillation Clinical Trial
	Pilot Study Evaluating the Toray Satake Balloon Thermal Ablation System for Treatment of Paroxysmal Atrial Fibrillation
		Status: Enrolling
  
							
  	
	Paroxysmal Atrial Fibrillation Clinical Trial
	Pilot Study Evaluating the Toray Satake Balloon Thermal Ablation System for Treatment of Paroxysmal Atrial Fibrillation
		Status: Enrolling	
	
	
			Updated: 7/17/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Retinal Vasculitis Clinical Trial
	Optical Coherence Tomography (OCT) in Retinal Vasculitis
		Status: Enrolling,
							Phase
  
							
  	
	Retinal Vasculitis Clinical Trial
	Optical Coherence Tomography (OCT) in Retinal Vasculitis
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 4/3/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Lung Cancer Clinical Trial
	Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Lung Cancer Clinical Trial
	Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
		Status: Enrolling,
							Phase
  
							
  	
	Oncology Clinical Trial
	Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 3/17/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Type 1 Diabetes Mellitus Clinical Trial
	Long Term Follow up of Recipients of Functional Islet Allografts
		Status: Enrolling,
							Phase
  
							
  	
	Type 1 Diabetes Mellitus Clinical Trial
	Long Term Follow up of Recipients of Functional Islet Allografts
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	The Cancer of the Pancreas Screening-5 CAPS5)Study
		Status: Enrolling,
							Phase
  
							
  	
	Oncology, Other Clinical Trial
	The Cancer of the Pancreas Screening-5 CAPS5)Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	The Cancer of the Pancreas Screening-5 CAPS5)Study
		Status: Enrolling,
							Phase
  
							
  	
	Oncology, Other Clinical Trial
	The Cancer of the Pancreas Screening-5 CAPS5)Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Multiple Myeloma Clinical Trial
	Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Multiple Myeloma Clinical Trial
	Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Oncology, Other Clinical Trial
	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
We've found
					184,457 
				
					clinical trials
				
				
				
	Chronic Idiopathic Constipation Clinical Trial
	
Updated: 4/25/2014
  
  
  A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 4/25/2014
Click here to add this to my saved trials
	    
	 
  	
	Chronic Idiopathic Constipation Clinical Trial
	
Updated: 4/25/2014
  
  
  A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 4/25/2014
Click here to add this to my saved trials
	    
	 
  	
	Chronic Idiopathic Constipation Clinical Trial
	
Updated: 4/25/2014
  
  
  A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 4/25/2014
Click here to add this to my saved trials
	    
	 
  	
	Healthy Clinical Trial
	
Updated: 2/19/2015
  
  
  Study of the Physical Activity in Anesthesiologists
		Status: Enrolling	
	Updated: 2/19/2015
Click here to add this to my saved trials
	    
	 
  	
	Nicotine Dependence Clinical Trial
	
Updated: 2/16/2016
  
  
  Very Low-Nicotine Cigarettes in Smokers With SUD
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 2/16/2016
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Metastatic Breast Cancer Clinical Trial
	
Updated: 3/6/2018
  
  
  Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 3/6/2018
Click here to add this to my saved trials
	    
	 
  	
	Metastatic Breast Cancer Clinical Trial
	
Updated: 3/6/2018
  
  
  Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 3/6/2018
Click here to add this to my saved trials
	    
	 
  	
	Metastatic Breast Cancer Clinical Trial
	
Updated: 3/6/2018
  
  
  Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 3/6/2018
Click here to add this to my saved trials
	    
	 
  	
	Metastatic Breast Cancer Clinical Trial
	
Updated: 3/6/2018
  
  
  Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 3/6/2018
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	
Updated: 11/15/2013
  
  
  Study of Use of CTC in NSCLC
		Status: Enrolling	
	Updated: 11/15/2013
Click here to add this to my saved trials
	    
	 
  	
	Rhinitis  Sinusitis Pediatric Chronic Rhinosinusitis Clinical Trial
	
Updated: 2/11/2015
  
  
  Study for the Management of Pediatric Chronic Rhinosinusitis With or Without Balloon Sinuplasty
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 2/11/2015
Click here to add this to my saved trials
	    
	 
  	
	Influenza Clinical Trial
	
Updated: 1/13/2015
  
  
  Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 1/13/2015
Click here to add this to my saved trials
	    
	 
  	
	Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Abdominal Aortic Aneurysm (AAA) Clinical Trial
	
Updated: 8/1/2016
  
  
  Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
		Status: Enrolling	
	Updated: 8/1/2016
Click here to add this to my saved trials
	    
	 
  	
	Abdominal Aortic Aneurysm (AAA) Clinical Trial
	
Updated: 8/1/2016
  
  
  Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
		Status: Enrolling	
	Updated: 8/1/2016
Click here to add this to my saved trials
	    
	 
  	
	Abdominal Aortic Aneurysm (AAA) Clinical Trial
	
Updated: 8/1/2016
  
  
  Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
		Status: Enrolling	
	Updated: 8/1/2016
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/12/2013
  
  
  Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/12/2013
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/12/2013
  
  
  Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/12/2013
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/12/2013
  
  
  Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/12/2013
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/12/2013
  
  
  Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/12/2013
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/12/2013
  
  
  Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/12/2013
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/12/2013
  
  
  Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/12/2013
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/12/2013
  
  
  Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/12/2013
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/12/2013
  
  
  Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/12/2013
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/12/2013
  
  
  Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/12/2013
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/12/2013
  
  
  Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/12/2013
Click here to add this to my saved trials
	    
	 
  	
	Genetics of Drug Metabolism Clinical Trial
	
Updated: 10/7/2014
  
  
  Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	Updated: 10/7/2014
Click here to add this to my saved trials
	    
	 
  	
	Genetics of Drug Metabolism Clinical Trial
	
Updated: 10/7/2014
  
  
  Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	Updated: 10/7/2014
Click here to add this to my saved trials
	    
	 
  	
	Genetics of Drug Metabolism Clinical Trial
	
Updated: 10/7/2014
  
  
  Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	Updated: 10/7/2014
Click here to add this to my saved trials
	    
	 
  	
	Genetics of Drug Metabolism Clinical Trial
	
Updated: 10/7/2014
  
  
  Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	Updated: 10/7/2014
Click here to add this to my saved trials
	    
	 
  	
	Genetics of Drug Metabolism Clinical Trial
	
Updated: 10/7/2014
  
  
  Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	Updated: 10/7/2014
Click here to add this to my saved trials
	    
	 
  	
	Genetics of Drug Metabolism Clinical Trial
	
Updated: 10/7/2014
  
  
  Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	Updated: 10/7/2014
Click here to add this to my saved trials
	    
	 
  	
	Genetics of Drug Metabolism Clinical Trial
	
Updated: 10/7/2014
  
  
  Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	Updated: 10/7/2014
Click here to add this to my saved trials
	    
	 
  	
	Genetics of Drug Metabolism Clinical Trial
	
Updated: 10/7/2014
  
  
  Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	Updated: 10/7/2014
Click here to add this to my saved trials
	    
	 
  	
	Genetics of Drug Metabolism Clinical Trial
	
Updated: 10/7/2014
  
  
  Diagnosing Adverse Drug Reactions Registry
		Status: Enrolling	
	Updated: 10/7/2014
Click here to add this to my saved trials
	    
	 
  	
	Breast Cancer Clinical Trial
	
Updated: 4/19/2018
  
  
  Cryoablation of Small Breast Tumors in Early Stage Breast Cancer
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	Updated: 4/19/2018
Click here to add this to my saved trials
	    
	 
  	
	Breast Cancer Clinical Trial
	
Updated: 4/19/2018
  
  
  Cryoablation of Small Breast Tumors in Early Stage Breast Cancer
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	Updated: 4/19/2018
Click here to add this to my saved trials
	    
	 
  	
	Multiple Sclerosis Clinical Trial
	
Updated: 9/3/2014
  
  
  Body Weight Supported Treadmill Training in Persons With Multiple Sclerosis
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 9/3/2014
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Reproductive Clinical Trial
	
Updated: 12/31/1969
  
  
  MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Reproductive Clinical Trial
	
Updated: 12/31/1969
  
  
  MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Urinary Tract Infections Clinical Trial
	
Updated: 12/31/1969
  
  
  Seven vs. 14 Days Treatment for Male Urinary Tract Infection
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Hematology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Lymphoma Clinical Trial
	
Updated: 12/31/1969
  
  
  Lenalidomide and GA101 in Relapsed Indolent Non-Hodgkin's Lymphoma
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Acromegaly Clinical Trial
	
Updated: 12/26/2015
  
  
  An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/26/2015
Click here to add this to my saved trials
	    
	 
  	
	Acromegaly Clinical Trial
	
Updated: 12/26/2015
  
  
  An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/26/2015
Click here to add this to my saved trials
	    
	 
  	
	Acromegaly Clinical Trial
	
Updated: 12/26/2015
  
  
  An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/26/2015
Click here to add this to my saved trials
	    
	 
  	
	Acromegaly Clinical Trial
	
Updated: 12/26/2015
  
  
  An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/26/2015
Click here to add this to my saved trials
	    
	 
  	
	Acromegaly Clinical Trial
	
Updated: 12/26/2015
  
  
  An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/26/2015
Click here to add this to my saved trials
	    
	 
  	
	Acromegaly Clinical Trial
	
Updated: 12/26/2015
  
  
  An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/26/2015
Click here to add this to my saved trials
	    
	 
  	
	Acromegaly Clinical Trial
	
Updated: 12/26/2015
  
  
  An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/26/2015
Click here to add this to my saved trials
	    
	 
  	
	Acromegaly Clinical Trial
	
Updated: 12/26/2015
  
  
  An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/26/2015
Click here to add this to my saved trials
	    
	 
  	
	Acromegaly Clinical Trial
	
Updated: 12/26/2015
  
  
  An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/26/2015
Click here to add this to my saved trials
	    
	 
  	
	Acromegaly Clinical Trial
	
Updated: 12/26/2015
  
  
  An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/26/2015
Click here to add this to my saved trials
	    
	 
  	
	Breast Cancer Stages I Through III Clinical Trial
	
Updated: 7/26/2014
  
  
  The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients
		Status: Enrolling	
	Updated: 7/26/2014
Click here to add this to my saved trials
	    
	 
  	
	Cerebral Vasospasm Clinical Trial
	
Updated: 12/31/1969
  
  
  The Intra-arterial Vasospasm Trial
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cerebral Vasospasm Clinical Trial
	
Updated: 12/31/1969
  
  
  The Intra-arterial Vasospasm Trial
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Paroxysmal Atrial Fibrillation Clinical Trial
	
Updated: 7/17/2014
  
  
  Pilot Study Evaluating the Toray Satake Balloon Thermal Ablation System for Treatment of Paroxysmal Atrial Fibrillation
		Status: Enrolling	
	Updated: 7/17/2014
Click here to add this to my saved trials
	    
	 
  	
	Retinal Vasculitis Clinical Trial
	
Updated: 4/3/2018
  
  
  Optical Coherence Tomography (OCT) in Retinal Vasculitis
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 4/3/2018
Click here to add this to my saved trials
	    
	 
  	
	Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 3/17/2016
  
  
  Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 3/17/2016
Click here to add this to my saved trials
	    
	 
  	
	Type 1 Diabetes Mellitus Clinical Trial
	
Updated: 12/31/1969
  
  
  Long Term Follow up of Recipients of Functional Islet Allografts
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  The Cancer of the Pancreas Screening-5 CAPS5)Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  The Cancer of the Pancreas Screening-5 CAPS5)Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  	
	Multiple Myeloma Clinical Trial
	
Updated: 12/31/1969
  
  
  Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	